Press Release 25 February 2009

Further to the announcement made earlier today, the Company confirms that a circular has now been dispatched to shareholders to convene a general meeting (“GM”) of the Company at 10.30 am on 16 March 2009 at the Company’s registered office, Holland Park, Holland Drive, Newcastle upon Tyne, NE2 4LZ. 

At the General Meeting the following resolutions will be proposed:

1. an ordinary resolution to increase the authorised share capital of the Company from £83,766.47 to £100,218.15 by the creation of an additional 16,451,684 new Ordinary Shares;
2. an ordinary resolution to authorise directors to allot relevant securities pursuant to section 80 of the Companies Act 1985 up to aggregate maximum nominal amount of £44,508.05; and
3. a special resolution to disapply the pre-emption provision contained in section 89(1) of the Companies Act 1985 in respect of the allotment of equity securities up to an aggregate nominal amount of £21,824.01 in connection with the authority referred to in (2) above.

-ENDS-

 For further information:

 John Cordiner, e-Therapeutics plc                 +44 (0) 191 233 1317

 Katy Mitchell/David Youngman WH Ireland Limited

                                                                       +44 (0) 113 394 6628

Media enquiries:

Abchurch Communications                           www.abchurch-group.com

                                                                       +44 (0) 207 398 7700

Heather Salmond

heather.salmond@abchurch-group.com       +44 (0) 207 398 7704

Stephanie Cuthbert

stephanie.cuthbert@abchurch-group.com     +44 (0) 207 398 7718

Simone Alves

simone.alves@abchurch-group.com             +44 (0) 207 398 7728